AI assistant
Sending…
BeOne Medicines Ltd. — Director's Dealing 2018
May 3, 2018
30073_dirs_2018-05-02_ab1fab6d-a6e1-4730-abaf-f2d5db3987a1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: BeiGene, Ltd. (BGNE)
CIK: 0001651308
Period of Report: 2018-04-30
Reporting Person: Wu Xiaobin (President and GM China)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| American Depositary Shares | 17365 | Direct |
| American Depositary Shares | 4000 | Indirect |
Footnotes
F1: Each American Depositary Share represents 13 Ordinary Shares.
More from BeOne Medicines Ltd.
Regulatory Filings
2026
May 15
Regulatory Filings
2026
May 6
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 6
Annual Report
2026
Apr 28
Proxy Solicitation & Information Statement
2026
Apr 28
Regulatory Filings
2026
Apr 14
Annual Report
2026
Feb 26
Regulatory Filings
2026
Feb 26
Director's Dealing
2026
Feb 6